The FDA Moves Towards a Streamlined Regulatory Process for Artificial Intelligence

A question that investors frequently ask of emerging growth life sciences companies is whether they have considered how to monetize the data they will inevitably collect in the development, marketing and sale of their service or product. Data merely existing in a compilation can have value; analytics can increase that value by orders of magnitude. Beyond compilation and analytics is the use of data to provide direct treatment or services. Using artificial intelligence (AI) (smart machines that are developed to do work normally done by Continue reading →

Common Noncompetition Agreement Mistakes by Employers

Noncompetition agreements are an increasing part of the employment landscape. Once considered unusual and only for C-suite employees, they are routinely required of entry-level employees. These types of agreements are highly technical and must clear several legal hurdles to be enforceable. The result is that they are poorly understood and implemented. I’m going to discuss several of the common mistakes made in drafting and implementing noncompetition agreements by employers. Some common employer mistakes are: Surprising existing employees without compensation. Noncompetition agreements are contracts; all contracts Continue reading →

Advising Life Sciences Clients on Private Equity

Life sciences/biotech companies are a significant economic driver in the greater Philadelphia area, with an estimated 1,200 businesses employing nearly 50,000 people in 2017.[1]  In my experience, there is significant growth within the early stage life sciences sector; most will need to seek capital to grow to an inflection point.  Much financing is through angel investors; what used to be a purely venture capital space has opened up to professional angels, primarily through investment groups such as The Keiretsu Forum, the Mid-Atlantic Bio Angels and Continue reading →

Settlement of Commercial Litigation Matters: Approaches and Issues to Keep in Mind

Settling commercial disputes frequently implicates a wide range of issues than settling personal matters; in this article I will discuss approaches and issues to keep in mind in resolving commercial disputes. By Christopher E. Ezold | April 17, 2018 The themes of commercial disputes are often the same as those of personal disputes—someone feels a promise was broken, blames another for property loss, or believes a duty was shirked. Instead of divorce or personal injury claims, however, these themes play out within more complex structures, Continue reading →

Attorney Ezold Publishes Litigation Hold Letter Article in The Legal Intelligencer

Attorney Christopher E. Ezold, a managing partner at the Ezold Law Firm, recently published an article in “The Legal Intelligencer” regarding the importance of litigation hold letters. In the article, he discusses the importance of litigation hold letters for clients in commercial disputes, and how it helps them in their cases. He reviews the fundamentals and time tables for their submission, and how they protect clients. With over 20 years of experience in commercial, business, and employment matters, Mr. Ezold represents both business and individual Continue reading →

First Court Ruling that ADA Title III Accessibility Applies to Website

Last week, Florida Federal District Judge Robert Scola ruled that Title III of the ADA required the Winn-Dixie website to be accessible to people with disabilities. In a bench trial, the plaintiff, a blind man using screen reading technology to access the internet, obtained injunctive relief.   Title III prohibits discrimination against people with disabilities in places of public accommodation.  This is the first court to hold that Title III accessibility requirements apply to a virtual space.  Judge Scola issued a verdict and draft injunction holding Continue reading →

Philadelphia Business Lawyers: No Cyber Liability Coverage for Knowing Refusal to Release Data

Last month, one of the first courts to address coverage under a cyber liability policy held that allegations of refusal to release data to a customer did not trigger a duty to defend the insured for technology errors and omissions liability. In Travelers Property and Casualty Company of America v. Federal Recovery Services et al., Travelers filed a declaratory judgment action to determine its obligation to defend its insured Federal Recovery Services, Inc.  Federal Recovery was in the business of processing, storage and transmission of Continue reading →

Philadelphia Health Law Attorneys: Are You An Accidental Business Associate?

It seems as though everyone knows that the Health Insurance Portability and Accountability Act (HIPAA) requires that patient health information (PHI) be kept secret, but very few understand who must comply with HIPAA, or how to comply.  This can be chalked up to the complexity of the law and lawmakers’ failure to educate the public.  Until late last year, only ‘covered entities,’ (CE) such as doctors and health plans, were responsible for complying with the extremely burdensome regulatory requirements of HIPAA. This changed on September Continue reading →